Mathematical Modeling of p53 Pathways
Abstract
:1. Introduction
2. p53 Dynamics in DNA Damage Response
2.1. Biological Background for Mathematical Model Development
2.2. Mathematical Models of p53 in the DNA Damage Response
2.3. Mathematical Modeling of p53 Interaction with Other Tumor Suppressors
3. p53 and Metabolism
3.1. Experimental Findings Regarding the Roles of p53 in Metabolism
3.2. Mathematical Models of Cancer Metabolism
4. Mathematical Models of Mitochondrial Physiology
4.1. Biological Background
4.2. Mathematical Models of Mitochondrial Physiology
5. Future Perspectives
6. Conclusions
Acknowledgments
Conflicts of Interest
Abbreviations
GADD45A | Growth arrest and DNA damage inducible alpha |
BTG2 | B-cell translocation gene 2 |
SFN | Stratifin |
CDKN1A | Cyclin dependent kinase inhibitor 1A |
BAX | Bcl2 associated protein X |
APAF1 | Apoptotic protease activating factor 1 |
AEN | Apoptosis enhancing nuclease |
FAS | Fas cell surface death receptor |
PERP | p53 apoptosis effector related to PMP-22 |
TRIAP1 | TP53 regulated inhibitor of apoptosis 1 |
BBC3 | Bcl-2 binding component 3 |
PMAIP1 | Phorbol 12 Myristate 13 acetate induced protein 1 |
SUSD6 | Sushi domain containing 6 |
XPC | Xeroderma pigmentosum |
PCNA | Proliferating cell nuclear antigen |
POLH | DNA polymerase eta |
RRM2B | Ribonucleotide reductase regulatory TP53 inducible subunit M2B. |
References
- Kandoth, C.; McLellan, M.D.; Vandin, F.; Ye, K.; Niu, B.; Lu, C.; Xie, M.; Zhang, Q.; McMichael, J.F.; Wyczalkowski, M.A.; et al. Mutational landscape and significance across 12 major cancer types. Nature 2013, 502, 333–339. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Riley, T.; Sontag, E.; Chen, P.; Levine, A. Transcriptional control of human p53-regulated genes. Nature Rev. Mol. Cell Biol. 2008, 9, 402–412. [Google Scholar] [CrossRef] [PubMed]
- Berkers, C.R.; Maddocks, O.D.; Cheung, E.C.; Mor, I.; Vousden, K.H. Metabolic regulation by p53 family members. Cell Metab. 2013, 18, 617–633. [Google Scholar] [CrossRef] [PubMed]
- Bieging, K.T.; Mello, S.S.; Attardi, L.D. Unravelling mechanisms of p53-mediated tumour suppression. Nat. Rev. Cancer 2014, 14, 359–370. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, T.; Kon, N.; Jiang, L.; Tan, M.; Ludwig, T.; Zhao, Y.; Baer, R.; Gu, W. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 2012, 149, 1269–1283. [Google Scholar] [CrossRef] [PubMed]
- Napoli, M.; Flores, E.R. The p53 family orchestrates the regulation of metabolism: Physiological regulation and implications for cancer therapy. Br. J. Cancer 2017, 116, 149–155. [Google Scholar] [CrossRef] [PubMed]
- Vousden, K.H.; Ryan, K.M. p53 and metabolism. Nat. Rev. Cancer 2009, 9, 691–700. [Google Scholar] [CrossRef]
- Floter, J.; Kaymak, I.; Schulze, A. Regulation of Metabolic Activity by p53. Metabolites 2017, 7. [Google Scholar] [CrossRef]
- Fischer, M. Census and evaluation of p53 target genes. Oncogene 2017, 36, 3943–3956. [Google Scholar] [CrossRef] [Green Version]
- El-Deiry, W.S.; Tokino, T.; Waldman, T.; Oliner, J.D.; Velculescu, V.E.; Burrell, M.; Hill, D.E.; Healy, E.; Rees, J.L.; Hamilton, S.R.; et al. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 1995, 55, 2910–2919. [Google Scholar]
- Miyashita, T.; Reed, J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80, 293–299. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nakano, K.; Vousden, K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 2001, 7, 683–694. [Google Scholar] [CrossRef]
- Bensaad, K.; Tsuruta, A.; Selak, M.A.; Vidal, M.N.; Nakano, K.; Bartrons, R.; Gottlieb, E.; Vousden, K.H. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126, 107–120. [Google Scholar] [CrossRef]
- Altrock, P.M.; Liu, L.L.; Michor, F. The mathematics of cancer: Integrating quantitative models. Nat. Rev. Cancer 2015, 15, 730–745. [Google Scholar] [CrossRef] [PubMed]
- De Jong, H. Modeling and simulation of genetic regulatory systems: A literature review. J. Comput. Biol. 2002, 9, 67–103. [Google Scholar] [CrossRef] [PubMed]
- Eungdamrong, N.J.; Iyengar, R. Modeling cell signaling networks. Biol. Cell 2004, 96, 355–362. [Google Scholar] [CrossRef] [PubMed]
- Gatenby, R. Perspective: Finding cancer’s first principles. Nature 2012, 491, S55. [Google Scholar] [CrossRef]
- Lindahl, T.; Barnes, D.E. Repair of endogenous DNA damage. Cold Spring Harb. Symp. Quant. Biol. 2000, 65, 127–133. [Google Scholar] [CrossRef]
- Haupt, Y.; Maya, R.; Kazaz, A.; Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387, 296–299. [Google Scholar] [CrossRef]
- Kubbutat, M.H.; Jones, S.N.; Vousden, K.H. Regulation of p53 stability by Mdm2. Nature 1997, 387, 299–303. [Google Scholar] [CrossRef]
- Barak, Y.; Juven, T.; Haffner, R.; Oren, M. mdm2 expression is induced by wild type p53 activity. EMBO J. 1993, 12, 461–468. [Google Scholar] [CrossRef] [PubMed]
- Verfaillie, A.; Svetlichnyy, D.; Imrichova, H.; Davie, K.; Fiers, M.; Kalender Atak, Z.; Hulselmans, G.; Christiaens, V.; Aerts, S. Multiplex enhancer-reporter assays uncover unsophisticated TP53 enhancer logic. Genome Res. 2016, 26, 882–895. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lahav, G.; Rosenfeld, N.; Sigal, A.; Geva-Zatorsky, N.; Levine, A.J.; Elowitz, M.B.; Alon, U. Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat. Genet. 2004, 36, 147–150. [Google Scholar] [CrossRef] [PubMed]
- Lev Bar-Or, R.; Maya, R.; Segel, L.A.; Alon, U.; Levine, A.J.; Oren, M. Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study. Proc. Natl. Acad. Sci. USA 2000, 97, 11250–11255. [Google Scholar] [CrossRef] [Green Version]
- Hamstra, D.A.; Bhojani, M.S.; Griffin, L.B.; Laxman, B.; Ross, B.D.; Rehemtulla, A. Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. Cancer Res. 2006, 66, 7482–7489. [Google Scholar] [CrossRef]
- Purvis, J.E.; Karhohs, K.W.; Mock, C.; Batchelor, E.; Loewer, A.; Lahav, G. p53 dynamics control cell fate. Science 2012, 336, 1440–1444. [Google Scholar] [CrossRef]
- Batchelor, E.; Loewer, A.; Mock, C.; Lahav, G. Stimulus-dependent dynamics of p53 in single cells. Mol. Syst. Biol. 2011, 7, 488. [Google Scholar] [CrossRef]
- Sun, T.; Cui, J. Dynamics of P53 in response to DNA damage: Mathematical modeling and perspective. Prog. Biophys. Mol. Biol. 2015, 119, 175–182. [Google Scholar] [CrossRef]
- Batchelor, E.; Loewer, A. Recent progress and open challenges in modeling p53 dynamics in single cells. Curr. Opin. Syst. Biol. 2017, 3, 54–59. [Google Scholar] [CrossRef]
- Sun, T.; Yang, W.; Liu, J.; Shen, P. Modeling the basal dynamics of p53 system. PLoS ONE 2011, 6, e27882. [Google Scholar] [CrossRef]
- Zhang, X.P.; Liu, F.; Wang, W. Two-phase dynamics of p53 in the DNA damage response. Proc. Natl. Acad. Sci. USA 2011, 108, 8990–8995. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, Z.; Ni, M.; Li, J.; Zhang, Y.; Ouyang, Q.; Tang, C. Decision making of the p53 network: Death by integration. J. Theor. Biol. 2011, 271, 205–211. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tian, X.J.; Liu, F.; Zhang, X.P.; Li, J.; Wang, W. A two-step mechanism for cell fate decision by coordination of nuclear and mitochondrial p53 activities. PLoS ONE 2012, 7, e38164. [Google Scholar] [CrossRef] [PubMed]
- Chen, X.; Chen, J.; Gan, S.; Guan, H.; Zhou, Y.; Ouyang, Q.; Shi, J. DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control. BMC Biol. 2013, 11, 73. [Google Scholar] [CrossRef]
- Zhang, T.; Brazhnik, P.; Tyson, J.J. Computational analysis of dynamical responses to the intrinsic pathway of programmed cell death. Biophys. J. 2009, 97, 415–434. [Google Scholar] [CrossRef]
- Zhuge, C.; Sun, X.; Chen, Y.; Lei, J. PDCD5 functions as a regulator of p53 dynamics in the DNA damage response. J. Theor. Biol. 2016, 388, 1–10. [Google Scholar] [CrossRef]
- Chong, K.H.; Samarasinghe, S.; Kulasiri, D.; Zheng, J. Mathematical modelling of core regulatory mechanism in p53 protein that activates apoptotic switch. J. Theor. Biol. 2019, 462, 134–147. [Google Scholar] [CrossRef]
- Toettcher, J.E.; Loewer, A.; Ostheimer, G.J.; Yaffe, M.B.; Tidor, B.; Lahav, G. Distinct mechanisms act in concert to mediate cell cycle arrest. Proc. Natl. Acad. Sci. USA 2009, 106, 785–790. [Google Scholar] [CrossRef] [Green Version]
- Zhang, X.P.; Liu, F.; Cheng, Z.; Wang, W. Cell fate decision mediated by p53 pulses. Proc. Natl. Acad. Sci. USA 2009, 106, 12245–12250. [Google Scholar] [CrossRef] [Green Version]
- Geva-Zatorsky, N.; Rosenfeld, N.; Itzkovitz, S.; Milo, R.; Sigal, A.; Dekel, E.; Yarnitzky, T.; Liron, Y.; Polak, P.; Lahav, G.; et al. Oscillations and variability in the p53 system. Mol. Syst. Biol. 2006, 2, 2006. [Google Scholar] [CrossRef]
- Moore, R.; Ooi, H.K.; Kang, T.; Bleris, L.; Ma, L. MiR-192-Mediated Positive Feedback Loop Controls the Robustness of Stress-Induced p53 Oscillations in Breast Cancer Cells. PLoS Comput. Biol. 2015, 11, e1004653. [Google Scholar] [CrossRef] [PubMed]
- Elias, J.; Dimitrio, L.; Clairambault, J.; Natalini, R. The dynamics of p53 in single cells: Physiologically based ODE and reaction-diffusion PDE models. Phys. Biol. 2014, 11, 045001. [Google Scholar] [CrossRef] [PubMed]
- Elias, J.; Dimitrio, L.; Clairambault, J.; Natalini, R. The p53 protein and its molecular network: Modelling a missing link between DNA damage and cell fate. Biochim. Biophys. Acta 2014, 1844, 232–247. [Google Scholar] [CrossRef] [PubMed]
- Wee, K.B.; Surana, U.; Aguda, B.D. Oscillations of the p53-Akt network: Implications on cell survival and death. PLoS ONE 2009, 4, e4407. [Google Scholar] [CrossRef] [PubMed]
- Tian, X.; Huang, B.; Zhang, X.P.; Lu, M.; Liu, F.; Onuchic, J.N.; Wang, W. Modeling the response of a tumor-suppressive network to mitogenic and oncogenic signals. Proc. Natl. Acad. Sci. USA 2017, 114, 5337–5342. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hat, B.; Kochanczyk, M.; Bogdal, M.N.; Lipniacki, T. Feedbacks, Bifurcations, and Cell Fate Decision-Making in the p53 System. PLoS Comput. Biol. 2016, 12, e1004787. [Google Scholar] [CrossRef]
- Mathupala, S.P.; Heese, C.; Pedersen, P.L. Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J. Biol. Chem. 1997, 272, 22776–22780. [Google Scholar] [CrossRef]
- Schwartzenberg-Bar-Yoseph, F.; Armoni, M.; Karnieli, E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004, 64, 2627–2633. [Google Scholar] [CrossRef]
- Su, X.; Gi, Y.J.; Chakravarti, D.; Chan, I.L.; Zhang, A.; Xia, X.; Tsai, K.Y.; Flores, E.R. TAp63 is a master transcriptional regulator of lipid and glucose metabolism. Cell Metab. 2012, 16, 511–525. [Google Scholar] [CrossRef]
- Liu, B.; Oltvai, Z.N.; Bayir, H.; Silverman, G.A.; Pak, S.C.; Perlmutter, D.H.; Bahar, I. Quantitative assessment of cell fate decision between autophagy and apoptosis. Sci. Rep. 2017, 7, 17605. [Google Scholar] [CrossRef]
- Yu, L.; Lu, M.; Jia, D.; Ma, J.; Ben-Jacob, E.; Levine, H.; Kaipparettu, B.A.; Onuchic, J.N. Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation. Cancer Res. 2017, 77, 1564–1574. [Google Scholar] [CrossRef]
- Markert, E.K.; Vazquez, A. Mathematical models of cancer metabolism. Cancer Metab. 2015, 3, 14. [Google Scholar] [CrossRef] [PubMed]
- Marin-Hernandez, A.; Gallardo-Perez, J.C.; Rodriguez-Enriquez, S.; Encalada, R.; Moreno-Sanchez, R.; Saavedra, E. Modeling cancer glycolysis. Biochim. Biophys. Acta 2011, 1807, 755–767. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shestov, A.A.; Liu, X.; Ser, Z.; Cluntun, A.A.; Hung, Y.P.; Huang, L.; Kim, D.; Le, A.; Yellen, G.; Albeck, J.G.; et al. Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting step. Elife 2014, 3. [Google Scholar] [CrossRef]
- Epstein, T.; Xu, L.; Gillies, R.J.; Gatenby, R.A. Separation of metabolic supply and demand: Aerobic glycolysis as a normal physiological response to fluctuating energetic demands in the membrane. Cancer Metab. 2014, 2, 7. [Google Scholar] [CrossRef] [PubMed]
- Gatenby, R.A.; Gawlinski, E.T. A reaction-diffusion model of cancer invasion. Cancer Res. 1996, 56, 5745–5753. [Google Scholar] [PubMed]
- Gatenby, R.A.; Gawlinski, E.T.; Gmitro, A.F.; Kaylor, B.; Gillies, R.J. Acid-mediated tumor invasion: A multidisciplinary study. Cancer Res. 2006, 66, 5216–5223. [Google Scholar] [CrossRef]
- Robertson-Tessi, M.; Gillies, R.J.; Gatenby, R.A.; Anderson, A.R. Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes. Cancer Res. 2015, 75, 1567–1579. [Google Scholar] [CrossRef]
- Senft, D.; Ronai, Z.A. Regulators of mitochondrial dynamics in cancer. Curr. Opin. Cell Biol. 2016, 39, 43–52. [Google Scholar] [CrossRef] [Green Version]
- Achanta, G.; Sasaki, R.; Feng, L.; Carew, J.S.; Lu, W.; Pelicano, H.; Keating, M.J.; Huang, P. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol γ. EMBO J. 2005, 24, 3482–3492. [Google Scholar] [CrossRef]
- Lebedeva, M.A.; Eaton, J.S.; Shadel, G.S. Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis. Biochim. Biophys. Acta 2009, 1787, 328–334. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bakhanashvili, M.; Grinberg, S.; Bonda, E.; Simon, A.J.; Moshitch-Moshkovitz, S.; Rahav, G. p53 in mitochondria enhances the accuracy of DNA synthesis. Cell Death Differ. 2008, 15, 1865–1874. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Park, J.H.; Zhuang, J.; Li, J.; Hwang, P.M. p53 as guardian of the mitochondrial genome. FEBS Lett. 2016, 590, 924–934. [Google Scholar] [CrossRef] [PubMed]
- Patel, P.K.; Shirihai, O.; Huang, K.C. Optimal dynamics for quality control in spatially distributed mitochondrial networks. PLoS Comput. Biol. 2013, 9, e1003108. [Google Scholar] [CrossRef] [PubMed]
- Zamponi, N.; Zamponi, E.; Cannas, S.A.; Billoni, O.V.; Helguera, P.R.; Chialvo, D.R. Mitochondrial network complexity emerges from fission/fusion dynamics. Sci. Rep. 2018, 8, 363. [Google Scholar] [CrossRef] [PubMed]
- Capps, G.J.; Samuels, D.C.; Chinnery, P.F. A model of the nuclear control of mitochondrial DNA replication. J. Theor. Biol. 2003, 221, 565–583. [Google Scholar] [CrossRef]
- Kowald, A.; Dawson, M.; Kirkwood, T.B. Mitochondrial mutations and ageing: Can mitochondrial deletion mutants accumulate via a size based replication advantage? J. Theor. Biol. 2014, 340, 111–118. [Google Scholar] [CrossRef] [PubMed]
- Sukhorukov, V.M.; Dikov, D.; Reichert, A.S.; Meyer-Hermann, M. Emergence of the mitochondrial reticulum from fission and fusion dynamics. PLoS Comput. Biol. 2012, 8, e1002745. [Google Scholar] [CrossRef]
- Mouli, P.K.; Twig, G.; Shirihai, O.S. Frequency and selectivity of mitochondrial fusion are key to its quality maintenance function. Biophys. J. 2009, 96, 3509–3518. [Google Scholar] [CrossRef]
- Tam, Z.Y.; Gruber, J.; Halliwell, B.; Gunawan, R. Mathematical modeling of the role of mitochondrial fusion and fission in mitochondrial DNA maintenance. PLoS ONE 2013, 8, e76230. [Google Scholar] [CrossRef]
- Gillespie, D.T. Stochastic simulation of chemical kinetics. Annu. Rev. Phys. Chem. 2007, 58, 35–55. [Google Scholar] [CrossRef] [PubMed]
- Kim, M.P.; Lozano, G. Mutant p53 partners in crime. Cell Death Differ. 2018, 25, 161–168. [Google Scholar] [CrossRef] [PubMed]
Biological Process | p53 Target Genes |
---|---|
Cell cycle arrest | GADD45A, BTG2, SFN, CDKN1A |
Apoptosis | BAX, APAF1, AEN, FAS, PERP, TRIAP1, BBC3, PMAIP1, SUSD6 |
DNA repair | XPC, PCNA, POLH, RRM2B |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kim, E.; Kim, J.-Y.; Lee, J.-Y. Mathematical Modeling of p53 Pathways. Int. J. Mol. Sci. 2019, 20, 5179. https://doi.org/10.3390/ijms20205179
Kim E, Kim J-Y, Lee J-Y. Mathematical Modeling of p53 Pathways. International Journal of Molecular Sciences. 2019; 20(20):5179. https://doi.org/10.3390/ijms20205179
Chicago/Turabian StyleKim, Eunjung, Jae-Young Kim, and Joo-Yong Lee. 2019. "Mathematical Modeling of p53 Pathways" International Journal of Molecular Sciences 20, no. 20: 5179. https://doi.org/10.3390/ijms20205179